An angel investor based in Cambridge, England, United Kingdom, Peter Keen has 15 known investments, including SupaPass, Horizon Discovery, Congenica, Cambridge Innovation Capital, Q Chip, Serentis, Small Pharma, Abcam PLC, Ark Therapeutics PLC, Biotech Growth Trust PLC, Endomagnetics Ltd. and Kiadis Pharma.
Is Peter Keen a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- FinTechHealthcare
Contacts
Peter Keen portfolio companies (15)
- SupaPass
- Horizon Discovery
- Congenica
- Cambridge Innovation Capital
- Q Chip
- Serentis
- Small Pharma
- Abcam PLC
- Ark Therapeutics PLC
- Biotech Growth Trust PLC
- Endomagnetics Ltd.
- Kiadis Pharma
- LifeArc
- Merlin Biosciences
- SpringWorks Therapeutics
Affiliated funds' portfolios
Independent Investment Committee member at British Business Bank, whose known portfolio counts 26 companies
- Wayve
- Paragraf
- Dexory
- Hadean
- Omega
- Sofant Technologies
- Regeno Energy
- ONEDOME
- Payr
- SteadyPay
- Auddy
- NeRRe Therapeutics
- and 14 more
Investor Profile
The known portfolio sits in sectors FinTech and Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and MedTech.
Peter Keen appears in Pre-Seed and Seed rounds across the known deals.
Reviewing the investment history helps decide whether there is a realistic fit before reaching out.
Colleagues at British Business Bank
Showing 20 of 26
George Mills
Director - Direct and Co-investments
London, United Kingdom
Tara Reeves
Non-Executive Director, BBB Investment Services Ltd
London, United Kingdom
Pinky Ghosh
Investor
United Kingdom
Costantino Mariella
Senior Investment Manager
London, United Kingdom
Gaynor Dykes
Director
West Lancashire, United Kingdom
Carrie Babcock
Senior Investment Manager
London, United Kingdom
Bali Muralidhar
Non Executive Director
London, United Kingdom
Jay Coulson
Funds Investment Analyst
Sheffield, United Kingdom
Ged Wilkinson
Investment Director
Watford, United Kingdom
Andy Littlewood
Investor
Sheffield, United Kingdom
Alex Butterworth
Investment Analyst
London, United Kingdom
Sajni Chotai
Investor
London, United Kingdom
Michael Laycock
Investment Director
Sheffield, United Kingdom
Christopher Amory
Investor
United Kingdom
Adam Kelly
Investor
London, United Kingdom
Robert Greenwood
Investor
London, United Kingdom
Elaine C.
Investment Committee Member
Ireland
Andrew Elder
Member of Investment Committee
London, United Kingdom
Sally Ann R.
Investor
Sheffield, United Kingdom
Jonathan Walker
Senior Investment Partner
London, United Kingdom
Similar investors
Showing 20 of 99
Jeffrey Kaditz
angel investor
George Mills
Director - Direct and Co-investments
London, United Kingdom
Joe Thornton
angel investor
London, United Kingdom
Chris Jackson
angel investor and operator angel
New York, United States
Peter Buckland
angel investor and operator angel
San Francisco, United States
Graham Hine
angel investor and operator angel
Beaconsfield, United Kingdom
Peter Hecht
angel investor and operator angel
Cambridge, United States
Alan Parnham
angel investor and operator angel
Southport, Australia
Graham Hobson
Advisor and supporter
London, United Kingdom
Kevin Keck
Managing Partner
London, United Kingdom
Bernie Rudnick
Co-Founder
Newark, United States
Govind Pindoria
angel investor
United Kingdom
Peter English
angel investor
Tonbridge, United Kingdom
Rockman Law
Investor
London, United Kingdom
Andrew Marciniec
angel investor
Malta
Jon Pickering
angel investor
London, United Kingdom
Peter Liddiard
angel investor
Portola Valley, United States
Guy Broadbent
angel investor
Boston, United States
Peter Cowley
angel investor
Cambridge, United Kingdom
Peder Bratt
Member Investor
London, United Kingdom
Frequently asked questions
Who is Peter Keen?
Peter Keen is an angel investor based in Cambridge, England, United Kingdom with 15 known investments on file, among them SupaPass, Horizon Discovery and Congenica. The sections above list the sectors, stages and firms attached to that record.
What does Peter Keen invest in?
Listed sectors include FinTech and Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and MedTech. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Peter Keen invest at?
The known deals of Peter Keen include Pre-Seed and Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Peter Keen listed at?
Peter Keen is listed as Independent Investment Committee member at British Business Bank. 26 other people in the database share a firm with Peter Keen.
How do I contact Peter Keen?
An email address, a phone number and a LinkedIn page are on file for Peter Keen. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal